Current Oncology · 2022 · 10 citations · 52 references
MedicineMolecular BiologyOncologyGene ExpressionMolecular OncologyNeoplasiaBone TumorsCancer ProgressionCancer TranscriptomicsMolecular Tumor ProfilingBone Tumor PrognosisDownstream Gene RegulationGene Ontology PredictionGiant Cell Tumor RecurrenceNf-κb SignalingProtein Expression LevelsRna SequencingRna Sequencing (Rna-seq)
The main features of a giant cell tumor of bone (GCTB) are frequent recurrence and aggressive osteolysis, which leads to a poor prognosis in patients. Although the treatment methods for a GCTB, such as scraping and resection, effectively inhibit the disease, the tendency toward malignant transformation remains. Therefore, it is important to identify new treatment methods for a GCTB. In this study, we first found high Siglec-15 expression in GCTB tissues, which was significantly associated with Campanacci staging and tumor recurrence. In Spearman's analysis, Siglec-15 expression was significantly correlated with Ki-67 levels in tumor tissues. In vitro, the mRNA and protein levels of Siglec-15 were high in GCTB stromal cells (Hs737. T), and Siglec-15 knockdown inhibited the biological characteristics of GCTB stromal cells. The RNA sequencing results enabled a prediction of the downstream genes by using the Kyoto Encyclopedia of Genes and Genomes (KEGG), Gene Ontology (GO), and MCODE analyses, and the findings showed that CXCL8 was significantly regulated by Siglec-15 and might be a promising downstream target gene of Siglec-15. Therefore, Siglec-15 may be a potential immunotherapy target for a GCTB.
52
Modulation of the antitumor immune response by complement
Maciej M. Markiewski, Robert A. DeAngelis, Fabián Benencia et al. · Nature Immunology · 2008 · 772 citations · Full text
Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
Jun Wang, Jingwei Sun, Linda N. Liu et al. · Nature Medicine · 2019 · 697 citations · Full text
Life Sciences, Immunology, Oncology +14
KRAS-IRF2 Axis Drives Immune Suppression and Immune Therapy Resistance in Colorectal Cancer
Wenting Liao, Michael J. Overman, Adam T. Boutin et al. · Cancer Cell · 2019 · 610 citations · Full text
Medicine, Cancer Biology, Oncology +16
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer’s Disease
Ana Griciuc, Shaun R. Patel, Anthony Federico et al. · Neuron · 2019 · 395 citations · Full text